Androgen-deprivation therapy in prostate cancer and cardiovascular risk

A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

Glenn N. Levine, Anthony V. D'Amico, Peter Berger, Peter E. Clark, Robert H. Eckel, Nancy L. Keating, Richard V. Milani, Arthur I Sagalowsky, Matthew R. Smith, Neil Zakai

Research output: Contribution to journalArticle

133 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)194-201
Number of pages8
JournalCA Cancer Journal for Clinicians
Volume60
Issue number3
DOIs
StatePublished - May 2010

Fingerprint

American Heart Association
Androgen Antagonists
Radiation Oncology
Antineoplastic Agents
Androgens
Prostatic Neoplasms
Cardiovascular Diseases
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Medicine(all)

Cite this

Androgen-deprivation therapy in prostate cancer and cardiovascular risk : A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology. / Levine, Glenn N.; D'Amico, Anthony V.; Berger, Peter; Clark, Peter E.; Eckel, Robert H.; Keating, Nancy L.; Milani, Richard V.; Sagalowsky, Arthur I; Smith, Matthew R.; Zakai, Neil.

In: CA Cancer Journal for Clinicians, Vol. 60, No. 3, 05.2010, p. 194-201.

Research output: Contribution to journalArticle

Levine, Glenn N. ; D'Amico, Anthony V. ; Berger, Peter ; Clark, Peter E. ; Eckel, Robert H. ; Keating, Nancy L. ; Milani, Richard V. ; Sagalowsky, Arthur I ; Smith, Matthew R. ; Zakai, Neil. / Androgen-deprivation therapy in prostate cancer and cardiovascular risk : A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology. In: CA Cancer Journal for Clinicians. 2010 ; Vol. 60, No. 3. pp. 194-201.
@article{228eb7520b574aa49a822a4f086a1bb1,
title = "Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology",
author = "Levine, {Glenn N.} and D'Amico, {Anthony V.} and Peter Berger and Clark, {Peter E.} and Eckel, {Robert H.} and Keating, {Nancy L.} and Milani, {Richard V.} and Sagalowsky, {Arthur I} and Smith, {Matthew R.} and Neil Zakai",
year = "2010",
month = "5",
doi = "10.3322/caac.20061",
language = "English (US)",
volume = "60",
pages = "194--201",
journal = "CA Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Androgen-deprivation therapy in prostate cancer and cardiovascular risk

T2 - A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

AU - Levine, Glenn N.

AU - D'Amico, Anthony V.

AU - Berger, Peter

AU - Clark, Peter E.

AU - Eckel, Robert H.

AU - Keating, Nancy L.

AU - Milani, Richard V.

AU - Sagalowsky, Arthur I

AU - Smith, Matthew R.

AU - Zakai, Neil

PY - 2010/5

Y1 - 2010/5

UR - http://www.scopus.com/inward/record.url?scp=77952568266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952568266&partnerID=8YFLogxK

U2 - 10.3322/caac.20061

DO - 10.3322/caac.20061

M3 - Article

VL - 60

SP - 194

EP - 201

JO - CA Cancer Journal for Clinicians

JF - CA Cancer Journal for Clinicians

SN - 0007-9235

IS - 3

ER -